لابراتوارهای دارویی رازک
درازک | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Cash Flow
AGM
Interim
2026/06/30 Fiscal Year 2026/03/2012 Month | 2026/06/29 Fiscal Year 2026/03/2012 Month / Audited | ||
|---|---|---|---|
Cash Generated from Operations | 2.781 Trillion | 2.781 Trillion | |
Income Taxes Paid | -124.791 Billion | -124.791 Billion | |
Net Cash Flow from Operating Activities | 2.656 Trillion | 2.656 Trillion | |
Purchases of Property, Plant and Equipment | -33.347 Billion | -33.347 Billion | |
Proceeds from Sale of Long-Term Investments | 1.038 Trillion | 1.038 Trillion | |
Cash Received from Income on Other Investments | 2.902 Billion | 2.902 Billion | |
Net Cash Flow from Investing Activities | 1.008 Trillion | 1.008 Trillion | |
Net Cash Flow before Financing Activities | 3.664 Trillion | 3.664 Trillion | |
Cash Received from Borrowings | 7.639 Trillion | 7.639 Trillion | |
Repayments of Borrowings (Principal) | -6.441 Trillion | -6.441 Trillion | |
Interest Paid on Borrowings | -3.58 Trillion | -3.58 Trillion | |
Dividends Paid | -957.392 Billion | -957.392 Billion | |
Net Cash Flow from Financing Activities | -3.34 Trillion | -3.34 Trillion | |
Net Increase (Decrease) in Cash | 324.548 Billion | 324.548 Billion | |
Cash at Beginning of Period | 3.148 Billion | 3.148 Billion | |
Cash at End of Period | 3.148 Billion | 327.696 Billion | |
Non-Cash Transactions | 1.477 Trillion | 1.477 Trillion |